Antoniom Risitano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antoniom Risitano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antoniom Risitano Today - Breaking & Trending Today

OncLive December Recap: FDA Approval Highlights

Published: December 30, 2023

In case you missed it, below are some of the drugs that were approved by the FDA in the month of December.

Source: onclive.com

Related Topics:

United KingdomFrance GeneralAntoniom RisitanoAerang KimLaurence AlbigesJennifera WoyachThomas PowlesGustave RoussyOnclive Peer ExchangeBone Marrow Transplantation ProgramBarts Cancer CentreDivision Of HematologyUniversity Of Naples FedericoOncologic Drugs Advisory CommitteeUniversity Of LondonChildren National HospitalOhio State University Comprehensive Cancer CenterVedotin Combo Snags ApprovalWins ApprovalGets Green LightPediatric High RiskYirang KimNational HospitalAssociate ProfessorParoxysmal Nocturnal

Final APPLY-PNH Data Support Use of Iptacopan in PNH With Persistent Anemia

Published: December 11, 2023

Oral iptacopan (Fabhalta) monotherapy induced durable responses and hemolysis control in patients with paroxysmal nocturnal hemoglobinuria and persistent anemia who had previously received anti-C5 treatment.

Source: onclive.com

Related Topics:

Antoniom RisitanoBone Marrow Transplantation ProgramUniversity Of Naples FedericoNaples FedericoOral Iptacopan Monotherapy Patients With Paroxysmal Nocturnal Hemoglobinuria And Persistent AnemiaApply Pnh TrialUniversity Of Naples Federico Ii